PeterLabs Holdings Bhd

KLSE:0171 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$16.50 Million
RM74.31 Million MYR
Market Cap Rank
#32326 Global
#753 in Malaysia
Share Price
RM0.27
Change (1 day)
+1.89%
52-Week Range
RM0.18 - RM0.45
All Time High
RM0.45
About

PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more

PeterLabs Holdings Bhd (0171) - Total Liabilities

Latest total liabilities as of September 2025: RM21.70 Million MYR

Based on the latest financial reports, PeterLabs Holdings Bhd (0171) has total liabilities worth RM21.70 Million MYR as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

PeterLabs Holdings Bhd - Total Liabilities Trend (2015–2024)

This chart illustrates how PeterLabs Holdings Bhd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

PeterLabs Holdings Bhd Competitors by Total Liabilities

The table below lists competitors of PeterLabs Holdings Bhd ranked by their total liabilities.

Liability Composition Analysis (2015–2024)

This chart breaks down PeterLabs Holdings Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.93 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.28 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PeterLabs Holdings Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PeterLabs Holdings Bhd (2015–2024)

The table below shows the annual total liabilities of PeterLabs Holdings Bhd from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 RM34.09 Million -8.23%
2023-12-31 RM37.15 Million +16.63%
2022-12-31 RM31.85 Million -18.63%
2021-12-31 RM39.15 Million +159.78%
2020-12-31 RM15.07 Million -25.62%
2019-12-31 RM20.26 Million -17.46%
2018-12-31 RM24.55 Million +5.89%
2017-12-31 RM23.18 Million +3.87%
2016-12-31 RM22.32 Million +93.89%
2015-12-31 RM11.51 Million --